Large AMC Sees Immediate ROI with AI-Driven Drug Diversion Surveillance

by Amanda Rogers, Marketing Content Writer, Protenus on December 15, 2022

Learn how leveraging Protenus' AI-powered Drug Diversion Surveillance solution resulted in immediate time savings for a large AMC. Our case-based approach provides a holistic picture so customers can focus on preventing drug diversion, not simply catching it.

The Challenge

A large Northeast-based AMC's decade-old legacy drug diversion program used a manual, report-based approach which was reactive, inefficient, and left it open to massive risk from drug diversion and potential violation of governmental regulations. The AMC also needed to standardize its drug diversion policies across all facilities and streamline the case detection, investigation, and resolution processes without increasing headcount.

Read the case study for more insight on how Protenus helped this large AMC realize a 93% time savings in the first 2 weeks post-implementation

The Solution

The team chose Protenus for its case-based approach, easy workflows, solid platform, and consolidated reporting that allowed managers to be very efficient with their time by reviewing high level risks at a glance instead of “living in the system”. Protenus provided the highest value return on investment (ROI) due to time savings, ease of use, ability to standardize diversion investigation and increase diversion investigation or policy deviation oversight.

AI-powered drug diversion surveillance and an automated workflow lets compliance professionals audit up to 100% of medication use transactions, identifying and surfacing inappropriate behavior that may otherwise go undetected as it happens, reducing risk to the organization, workforce, and most importantly, patients.

The Results

Protenus’ drug diversion surveillance solution delivered immediate ROI in terms of 93% time savings. It also gave the AMC a real-time view of what was happening with diversion incidents so it could take advantage of opportunities to reinforce education and strengthen policy adherence, further reducing risk.

In the first two weeks post-implementation, the Protenus solution surfaced inappropriate behavior that turned out to be a verified diversion case due to the reliability of the platform in populating valuable data immediately following implementation. The Compliance Manager was able to see the case from open to close in just over two hours, representing a 93% time savings over the previous legacy system.

Protenus also helped the AMC easily compare different drug diversion efforts across its multiple hospital locations and standardize compliance policies throughout the system.

Read the case study for more insight on how an AI-powered drug diversion surveillance solution reduced diversion incident investigation and resolution time by 93%